Observational studyBMC musculoskeletal disorders2026
Risk stratification of surgical site infection in high-risk spine surgery under prophylactic ciNPWT.
Observational study in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis retrospective observational single-center cohort study evaluated real-world outcomes of prophylactic closed-incision negative pressure wound therapy (ciNPWT) in high-risk spine surgery patients and explored the distribution of surgical site infection (SSI) across cumulative risk burden (RiskN) strata within this selectively treated cohort.
methodsWe reviewed consecutive spine surgery patients who received prophylactic single-use PICO 7 (Smith & Nephew) ciNPWT immediately after wound closure between April 2023 and October 2025. High-risk status was defined according to Japanese reimbursable criteria. Cumulative risk burden was quantified as RiskN (1, 2, or ≥ 3). SSI was defined based on CDC criteria and reported with Wilson 95% confidence intervals (CIs).
resultsA total of 104 patients were analyzed (mean age 70.2 ± 12.7 years; BMI 24.1 ± 4.5 kg/m²). The mean RiskN was 1.50 ± 0.78 (RiskN 1: 68 patients; RiskN 2: 22; RiskN 3–4: 14). The most frequent risk factor was hypoalbuminemia (57/104, 54.8%). Overall SSI occurred in 4 of 104 patients (3.8%; 95% CI, 1.5–9.5%). SSI rates were 2.9% (2/68) in RiskN 1, 0% (0/22) in RiskN 2, and 14.3% (2/14) in RiskN ≥ 3. Surgical procedures were mainly lumbar posterior (56/104, 53.8%) and thoracolumbar posterior (21/104, 20.2%); SSIs occurred after thoracolumbar posterior surgery (2/21), cervical posterior surgery (1/14), and lumbar posterior surgery (1/56). The most commonly used dressing size was 15 × 15 cm (51/104, 49.0%).
conclusionsIn this selectively treated, reimbursement-linked high-risk spine surgery cohort managed with prophylactic ciNPWT, SSI was uncommon overall but remained observed in patients with higher cumulative risk burden. RiskN was used to contextualize residual SSI risk within this pragmatically treated population. The observed SSI rate should be interpreted as a residual (“breakthrough”) infection rate within a high-risk population. As a descriptive study without a control group, this study does not directly demonstrate the treatment effect of ciNPWT. Further comparative studies are needed to determine its incremental benefit, cost-effectiveness, and appropriate indications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.